Hippocampal subregions are differentially affected in the progression to Alzheimer's disease

Anatomical Record

Volumn 295, Issue 1, 2012, Pages 132-140

  Greene, Sarah J ^a,b   Killiany, Ronald J ^b,c  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Alzheimer's disease; FreeSurfer; MCI; MRI; Neuropsychology

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E4; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; CEREBROSPINAL FLUID; DISEASE COURSE; FEMALE; FOLLOW UP; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WECHSLER INTELLIGENCE SCALE;

AGED; ALZHEIMER DISEASE; COGNITION DISORDERS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE;

EID: 83655161357     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.21493     Document Type: Article

References (84)

1. Bernasconi N, Bernasconi A, Caramanos Z, Antel SB, Andermann F, Arnold DL. 2003. Mesial temporal damage in temporal lobe epilepsy: A volumetric MRI study of the hippocampus, amygdala and parahippocampal region. Brain 126: 462-469.
2. Blennow K, Wallin A, Agren H, Spenger C, Siegfried J, Vanmechelen E. 1995. Tau protein in cerebrospinal fluid: A biochemical marker for axonal degeneration in Alzheimer disease? Mol Chem Neuropathol 26: 231-245.
3. Bouchard TP, Malykhin N, Martin WR, Hanstock CC, Emery DJ, Fisher NJ, Camicioli RM. 2008. Age and dementia-associated atrophy predominates in the hippocampal head and amygdala in Parkinson's disease. Neurobiol Aging 29: 1027-1039.
4. Bouras C, Hof PR, Giannakopoulos P, Michel JP, Morrison JH. 1994. Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: A quantitative evaluation of a one-year autopsy population from a geriatric hospital. Cereb Cortex 4: 138-150.
5. Bouras C, Hof PR, Morrison JH. 1993. Neurofibrillary tangle densities in the hippocampal formation in a non-demented population define subgroups of patients with differential early pathologic changes. Neurosci Lett 153: 131-135.
6. Bourgeat P, Chetelat G, Villemagne VL, Fripp J, Raniga P, Pike K, Acosta O, Szoeke C, Ourselin S, Ames D, Ellis KA, Martins RN, Masters CL, Rowe CC, Salvado O. 2010. Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia. Neurology 74: 121-127.
7. Braak H, Braak E. 1991. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: 239-259.
8. Braak H, Braak E, Bohl J. 1993. Staging of Alzheimer-related cortical destruction. Eur Neurol 33: 403-408.
9. Bronen RA, Fulbright RK, Kim JH, Spencer SS, Spencer DD, Al-Rodhan NR. 1995. Regional distribution of MR findings in hippocampal sclerosis. AJNR Am J Neuroradiol 16: 1193-1200.
10. Buckner RL, Head D, Parker J, Fotenos AF, Marcus D, Morris JC, Snyder AZ. 2004. A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: Reliability and validation against manual measurement of total intracranial volume. Neuroimage 23: 724-738.
11. Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, Sheline YI, Klunk WE, Mathis CA, Morris JC, Mintun MA. 2005. Molecular, structural, and functional characterization of Alzheimer's disease: Evidence for a relationship between default activity, amyloid, and memory. J Neurosci 25: 7709-7717.
12. Calhoun ME, Mao Y, Roberts JA, Rapp PR. 2004. Reduction in hippocampal cholinergic innervation is unrelated to recognition memory impairment in aged rhesus monkeys. J Comp Neurol 475: 238-246.
13. Callen DJ, Black SE, Gao F, Caldwell CB, Szalai JP. 2001. Beyond the hippocampus: MRI volumetry confirms widespread limbic atrophy in AD. Neurology 57: 1669-1674.
14. Chen KH, Chuah LY, Sim SK, Chee MW. 2010. Hippocampal region-specific contributions to memory performance in normal elderly. Brain Cogn 72: 400-407.
15. Chetelat G, Landeau B, Eustache F, Mezenge F, Viader F, de la Sayette V, Desgranges B, Baron JC. 2005. Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: A longitudinal MRI study. Neuroimage 27: 934-946.
16. Chetelat G, Villemagne VL, Bourgeat P, Pike KE, Jones G, Ames D, Ellis KA, Szoeke C, Martins RN, O'Keefe GJ, Salvado O, Masters CL, Rowe CC. 2010. Relationship between atrophy and beta-amyloid deposition in Alzheimer disease. Ann Neurol 67: 317-324.
17. Chua EF, Schacter DL, Rand-Giovannetti E, Sperling RA. 2007. Evidence for a specific role of the anterior hippocampal region in successful associative encoding. Hippocampus 17: 1071-1080.
18. Convit A, de Asis J, de Leon MJ, Tarshish CY, De Santi S, Rusinek H. 2000. Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease. Neurobiol Aging 21: 19-26.
19. Csernansky JG, Wang L, Swank J, Miller JP, Gado M, McKeel D, Miller MI, Morris JC. 2005. Preclinical detection of Alzheimer's disease: Hippocampal shape and volume predict dementia onset in the elderly. Neuroimage 25: 783-792.
20. Dale AM, Fischl B, Sereno MI. 1999. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 9: 179-194.
21. Dale AM, Sereno, MI. 1993. Improved localization of cortical activity by combining EEG and MEG with MRI cortical surface reconstruction: A linear approach. J Cogn Neurosci 5: 162-176.
22. de Leon MJ, Mosconi L, Blennow K, DeSanti S, Zinkowski R, Mehta PD, Pratico D, Tsui W, Saint Louis LA, Sobanska L, Brys M, Li Y, Rich K, Rinne J, Rusinek H. 2007. Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease. Ann N Y Acad Sci 1097: 114-145.
23. den Heijer T, Geerlings MI, Hoebeek FE, Hofman A, Koudstaal PJ, Breteler MM. 2006. Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people. Arch Gen Psychiatry 63: 57-62.
24. Desikan RS, Fischl B, Cabral HJ, Kemper TL, Guttmann CR, Blacker D, Hyman BT, Albert MS, Killiany RJ. 2008. MRI measures of temporoparietal regions show differential rates of atrophy during prodromal AD. Neurology 71: 819-825.
25. Desikan RS, Segonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, Buckner RL, Dale AM, Maguire RP, Hyman BT, Albert MS, Killiany RJ. 2006. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31: 968-980.
26. Devanand DP, Liu X, Tabert MH, Pradhaban G, Cuasay K, Bell K, de Leon MJ, Doty RL, Stern Y, Pelton GH. 2008. Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease. Biol Psychiatry 64: 871-879.
27. Devanand DP, Pradhaban G, Liu X, Khandji A, De Santi S, Segal S, Rusinek H, Pelton GH, Honig LS, Mayeux R, Stern Y, Tabert MH, de Leon MJ. 2007. Hippocampal and entorhinal atrophy in mild cognitive impairment: Prediction of Alzheimer disease. Neurology 68: 828-836.
28. Ekstrom AD, Bazih AJ, Suthana NA, Al-Hakim R, Ogura K, Zeineh M, Burggren AC, Bookheimer SY. 2009. Advances in high-resolution imaging and computational unfolding of the human hippocampus. Neuroimage 47: 42-49.
29. Fischl B, Dale AM. 2000. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci USA 97: 11050-11055.
30. Fischl B, Liu A, Dale AM. 2001. Automated manifold surgery: Constructing geometrically accurate and topologically correct models of the human cerebral cortex. IEEE Trans Med Imaging 20: 70-80.
31. Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, van der Kouwe A, Killiany R, Kennedy D, Klaveness S, Montillo A, Makris N, Rosen B, Dale AM. 2002. Whole brain segmentation: Automated labeling of neuroanatomical structures in the human brain. Neuron 33: 341-355.
32. Fischl B, Salat DH, van der Kouwe AJ, Makris N, Segonne F, Quinn BT, Dale AM. 2004a. Sequence-independent segmentation of magnetic resonance images. Neuroimage 23(Suppl 1): S69-S84.
33. Fischl B, Sereno MI, Dale AM. 1999. Cortical surface-based analysis. II. Inflation, flattening, and a surface-based coordinate system. Neuroimage 9: 195-207.
34. Fischl B, van der Kouwe A, Destrieux C, Halgren E, Segonne F, Salat DH, Busa E, Seidman LJ, Goldstein J, Kennedy D, Caviness V, Makris N, Rosen B, Dale AM. 2004b. Automatically parcellating the human cerebral cortex. Cereb Cortex 14: 11-22.
35. Fleisher AS, Sun S, Taylor C, Ward CP, Gamst AC, Petersen RC, Jack CR, Jr, Aisen PS, Thal LJ. 2008. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment. Neurology 70: 191-199.
36. Folstein MF, Folstein SE, McHugh PR. 1975. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198.
37. Fox NC, Warrington EK, Freeborough PA, Hartikainen P, Kennedy AM, Stevens JM, Rossor MN. 1996. Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. Brain 119(Pt 6): 2001-2007.
38. Frank RA, Galasko D, Hampel H, Hardy J, de Leon MJ, Mehta PD, Rogers J, Siemers E, Trojanowski JQ. 2003. Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease. Neurobiol Aging 24: 521-536.
39. Giannakopoulos P, Hof PR, Mottier S, Michel JP, Bouras C. 1994. Neuropathological changes in the cerebral cortex of 1258 cases from a geriatric hospital: Retrospective clinicopathological evaluation of a 10-year autopsy population. Acta Neuropathol 87: 456-468.
40. Hackert VH, den Heijer T, Oudkerk M, Koudstaal PJ, Hofman A, Breteler MM. 2002. Hippocampal head size associated with verbal memory performance in nondemented elderly. Neuroimage 17: 1365-1372.
41. Han X, Jovicich J, Salat D, van der Kouwe A, Quinn B, Czanner S, Busa E, Pacheco J, Albert M, Killiany R, Maguire P, Rosas D, Makris N, Dale A, Dickerson B, Fischl B. 2006. Reliability of MRI-derived measurements of human cerebral cortical thickness: The effects of field strength, scanner upgrade and manufacturer. Neuroimage 32: 180-194.
42. Haroutunian V, Purohit DP, Perl DP, Marin D, Khan K, Lantz M, Davis KL, Mohs RC. 1999. Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease. Arch Neurol 56: 713-718.
43. Hyman BT. 1997. The neuropathological diagnosis of Alzheimer's disease: Clinical-pathological studies. Neurobiol Aging 18: S27-S32.
44. Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL. 1984. Alzheimer's disease: Cell-specific pathology isolates the hippocampal formation. Science 225: 1168-1170.
45. Hyman BT, Van Hoesen GW, Kromer LJ, Damasio AR. 1986. Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann Neurol 20: 472-481.
46. Jack CR, Jr, Bernstein MA, Fox NC, Thompson P, Alexander G, Harvey D, Borowski B, Britson PJ, Whitwell LJ, Ward C, Dale AM, Felmlee JP, Gunter JL, Hill DL, Killiany R, Schuff N, Fox-Bosetti S, Lin C, Studholme C, DeCarli CS, Krueger G, Ward HA, Metzger GJ, Scott KT, Mallozzi R, Blezek D, Levy J, Debbins JP, Fleisher AS, Albert M, Green R, Bartzokis G, Glover G, Mugler J, Weiner MW. 2008a. The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging 27: 685-691.
47. Jack CR, Jr, Lowe VJ, Senjem ML, Weigand SD, Kemp BJ, Shiung MM, Knopman DS, Boeve BF, Klunk WE, Mathis CA, Petersen RC. 2008b. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain 131: 665-680.
48. Jack CR, Jr, Shiung MM, Weigand SD, O'Brien PC, Gunter JL, Boeve BF, Knopman DS, Smith GE, Ivnik RJ, Tangalos EG, Petersen RC. 2005. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology 65: 1227-1231.
49. Jovicich J, Czanner S, Greve D, Haley E, van der Kouwe A, Gollub R, Kennedy D, Schmitt F, Brown G, Macfall J, Fischl B, Dale A. 2006. Reliability in multi-site structural MRI studies: Effects of gradient non-linearity correction on phantom and human data. Neuroimage 30: 436-443.
50. Kaplan EF, Goodglass H, Weintraub S. 1983. The boston naming test. Philadelphia: Lea and Febiger.
51. Killiany RJ, Hyman BT, Gomez-Isla T, Moss MB, Kikinis R, Jolesz F, Tanzi R, Jones K, Albert MS. 2002. MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology 58: 1188-1196.
52. Lepage M, Habib R, Tulving E. 1998. Hippocampal PET activations of memory encoding and retrieval: The HIPER model. Hippocampus 8: 313-322.
53. Malykhin NV, Lebel RM, Coupland NJ, Wilman AH, Carter R. 2010. In vivo quantification of hippocampal subfields using 4.7 T fast spin echo imaging. Neuroimage 49: 1224-1230.
54. Martin SB, Smith CD, Collins HR, Schmitt FA, Gold BT. 2010. Evidence that volume of anterior medial temporal lobe is reduced in seniors destined for mild cognitive impairment. Neurobiol Aging 31: 1099-1106.
55. Mormino EC, Kluth JT, Madison CM, Rabinovici GD, Baker SL, Miller BL, Koeppe RA, Mathis CA, Weiner MW, Jagust WJ. 2009. Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain 132: 1310-1323.
56. Mueller SG, Stables L, Du AT, Schuff N, Truran D, Cashdollar N, Weiner MW. 2007. Measurement of hippocampal subfields and age-related changes with high resolution MRI at 4T. Neurobiol Aging 28: 719-726.
57. Ouchi Y, Nobezawa S, Okada H, Yoshikawa E, Futatsubashi M, Kaneko M. 1998. Altered glucose metabolism in the hippocampal head in memory impairment. Neurology 51: 136-142.
58. Price JL, Davis PB, Morris JC, White DL. 1991. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging 12: 295-312.
59. Price JL, Morris JC. 1999. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol 45: 358-368.
60. Reckess G. Antecedent biomarkers in Alzheimer's disease: Uses, limitations, and future directions for research. In: Morris JC, Chair, editor. 2003. St. Louis, Missouri: Washington University Alzheimer's Disease Research Center.
61. Reitan RM. 1958. Validity of the trail making tests as an indicator of organic brain damage. Perception Motor Skills 8: 253-266.
62. Rey A. 1964. L'Examen clinique en psychologie. Paris: Presses Universitaires de France.
63. Risacher SL, Saykin AJ, West JD, Shen L, Firpi HA, McDonald BC. 2009. Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort. Curr Alzheimer Res 6: 347-361.
64. Rosazza C, Minati L, Ghielmetti F, Maccagnano E, Erbetta A, Villani F, Epifani F, Spreafico R, Bruzzone MG. 2009. Engagement of the medial temporal lobe in verbal and nonverbal memory: Assessment with functional MR imaging in healthy subjects. AJNR Am J Neuroradiol 30: 1134-1141.
65. Rosen WG, Mohs RC, Davis KL. 1984. A new rating scale for Alzheimer's disease. Am J Psychiatry 141: 1356-1364.
66. Rosene DL, Van Hoesen GV. 1987. The hippocampal formation of the primate brain: A review of some comparative aspects of cytoarchitecture and connections. In: Jones EG, Peters A, editors. Cerebral Cortex. New York: Plenum Press. p 345-456.
67. Segonne F, Dale AM, Busa E, Glessner M, Salat D, Hahn HK, Fischl B. 2004. A hybrid approach to the skull stripping problem in MRI. Neuroimage 22: 1060-1075.
68. Segonne F, Pacheco J, Fischl B. 2007. Geometrically accurate topology-correction of cortical surfaces using nonseparating loops. IEEE Trans Med Imaging 26: 518-529.
69. Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter W, Lee VM, Trojanowski JQ. 2009. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol 65: 403-413.
70. Storandt M, Mintun MA, Head D, Morris JC. 2009. Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: Cognitive decline associated with Abeta deposition. Arch Neurol 66: 1476-1481.
71. Strange BA, Fletcher PC, Henson RN, Friston KJ, Dolan RJ. 1999. Segregating the functions of human hippocampus. Proc Natl Acad Sci USA 96: 4034-4039.
72. Strozyk D, Blennow K, White LR, Launer LJ. 2003. CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study. Neurology 60: 652-656.
73. Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, Pirttila T. 2009. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch Neurol 66: 382-389.
74. Tapiola T, Overmyer M, Lehtovirta M, Helisalmi S, Ramberg J, Alafuzoff I, Riekkinen P, Sr, Soininen H. 1997. The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's disease. Neuroreport 8: 3961-3963.
75. Theysohn JM, Kraff O, Maderwald S, Schlamann MU, de Greiff A, Forsting M, Ladd SC, Ladd ME, Gizewski ER. 2009. The human hippocampus at 7 T-In vivo MRI. Hippocampus 19: 1-7.
76. Ulrich J. 1985. Alzheimer changes in nondemented patients younger than sixty-five: Possible early stages of Alzheimer's disease and senile dementia of Alzheimer type. Ann Neurol 17: 273-277.
77. Van Hoesen GW, Hyman BT. 1990. Hippocampal formation: Anatomy and the patterns of pathology in Alzheimer's disease. Prog Brain Res 83: 445-457.
78. Van Leemput K, Bakkour A, Benner T, Wiggins G, Wald LL, Augustinack J, Dickerson BC, Golland P, Fischl B. 2009. Automated segmentation of hippocampal subfields from ultra-high resolution in vivo MRI. Hippocampus 19: 549-557.
79. Walhovd KB, Fjell AM, Brewer J, McEvoy LK, Fennema-Notestine C, Hagler DJ, Jr, Jennings RG, Karow D, Dale AM. 2010. Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease. AJNR Am J Neuroradiol 31: 347-354.
80. Witthaus H, Mendes U, Brune M, Ozgurdal S, Bohner G, Gudlowski Y, Kalus P, Andreasen N, Heinz A, Klingebiel R, Juckel G. 2010. Hippocampal subdivision and amygdalar volumes in patients in an at-risk mental state for schizophrenia. J Psychiatry Neurosci 35: 33-40.
81. Yushkevich PA, Avants BB, Das SR, Pluta J, Altinay M, Craige C. 2010. Bias in estimation of hippocampal atrophy using deformation-based morphometry arises from asymmetric global normalization: An illustration in ADNI 3 T MRI data. Neuroimage 50: 434-445.
82. Yushkevich PA, Avants BB, Pluta J, Das S, Minkoff D, Mechanic-Hamilton D, Glynn S, Pickup S, Liu W, Gee JC, Grossman M, Detre JA. 2009. A high-resolution computational atlas of the human hippocampus from postmortem magnetic resonance imaging at 9.4 T. Neuroimage 44: 385-398.
83. Zeineh MM, Engel SA, Bookheimer SY. 2000. Application of cortical unfolding techniques to functional MRI of the human hippocampal region. Neuroimage 11: 668-683.
84. Zeineh MM, Engel SA, Thompson PM, Bookheimer SY. 2001. Unfolding the human hippocampus with high resolution structural and functional MRI. Anat Rec 265: 111-120.